Skip to main content
. 2020 Sep 23:1–15. doi: 10.1080/07391102.2020.1825232

Figure 1.

Figure 1.

The flow chart depicts the process of drug repurposing where a marketed drug or a drug which has already been tested safe in preclinical and clinical settings is repurposed for treating a new disease. These drugs can either be natural, semi-synthetic or synthetic compounds.